文献速递心脑血管急症重症综合管理与镇静镇痛

脑室内出血后迟发性慢性脑积水分层风险列线图的开发与验证:多中心回顾性队列研究

Development and Validation of a Novel Nomogram for Risk Stratification of Posthemorrhagic Chronic Hydrocephalus Following Intraventricular Hemorrhage: A Multicenter Retrospective Cohort Study.
PubMed 文献 · Neurocrit Care · 2026-01-08
一句话结论在7中心280例脑室内出血患者中开发并验证了首个预测迟发性慢性脑积水的列线图,训练集C-index 0.850,验证集0.785。

该多中心回顾性队列研究纳入中国7个中心2020年12月至2022年12月收治的脑室内出血患者,且外引流管理限于最多2周、期间未置入分流管,共280例,按7:3随机分为训练集和验证集。82例(29.3%)发生慢性脑积水。通过LASSO回归和多因素logistic回归识别出急性脑积水、24小时脑室内血肿体积和入院时脑实质血肿体积三个显著预测因素,并构建列线图。训练集C-index 0.850(95%CI 0.791-0.909),验证集0.785(95%CI 0.649-0.922);训练集AUC 0.826(95%CI 0.756-0.896),验证集AUC 0.785(95%CI 0.661-0.910)。校准曲线和Hosmer-Lemeshow检验显示模型预测与实际观察一致性良好,决策曲线分析显示训练集在8%至80%、验证集在18%至95%的阈值概率范围内提供临床净获益。作者认为该列线图可为个体化风险分层和临床决策提供工具。

要点

  • 在7中心280例脑室内出血患者中,82例(29.3%)发生迟发性慢性脑积水。
  • 急性脑积水、24小时脑室内血肿体积和入院时脑实质血肿体积是迟发性慢性脑积水的显著预测因素。
  • 列线图训练集C-index 0.850(95%CI 0.791-0.909),验证集C-index 0.785(95%CI 0.649-0.922),均超过0.70的临床效用阈值。
  • 训练集AUC 0.826(95%CI 0.756-0.896),验证集AUC 0.785(95%CI 0.661-0.910)。
  • 决策曲线分析显示训练集阈值概率8%至80%、验证集18%至95%范围内有临床净获益。

适用人群与场景

  • 中国7个中心2020年12月至2022年12月收治的脑室内出血患者,外引流管理限于最多2周且期间未置入分流管。

研究设计与关键结果

  • 多中心回顾性队列研究,共纳入280例脑室内出血患者,按7:3随机分为训练集和验证集,82例(29.3%)发生迟发性慢性脑积水。
  • LASSO回归和多因素logistic回归识别出急性脑积水、24小时脑室内血肿体积和入院时脑实质血肿体积三个显著预测因素并构建列线图。
  • 训练集C-index 0.850(95%CI 0.791-0.909),验证集C-index 0.785(95%CI 0.649-0.922);训练集AUC 0.826(95%CI 0.756-0.896),验证集AUC 0.785(95%CI 0.661-0.910)。
  • 校准曲线和Hosmer-Lemeshow检验显示列线图模型预测与实际观察一致性良好。
  • 决策曲线分析显示列线图在训练集阈值概率8%至80%、验证集18%至95%范围内提供临床净获益。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为该列线图可为脑室内出血患者迟发性慢性脑积水的个体化风险分层和临床决策提供有价值工具。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: To develop and validate the first nomogram for the individualized risk assessment of posthemorrhagic chronic hydrocephalus in patients with intraventricular hemorrhage (IVH).

METHODS: This multicenter retrospective cohort study analyzed clinical data from patients with IVH treated at seven centers in China between December 2020 and December 2022. The study population specifically comprised patients whose external ventricular drain management was limited to a maximum of 2 weeks, without shunt placement during this period. Patients were randomly categorized into training and validation sets (7:3 ratio). Key predictors were identified using LASSO regression and multivariable logistic regression. Model performance was assessed via the C-index, area under the receiver operating characteristic curve, calibration curves, and decision curve analysis.

RESULTS: A total of 280 patients were included in the study, of whom 82 (29.3%) developed chronic hydrocephalus. Three risk factors, including acute hydrocephalus, ventricular hematoma volume at 24 h, and parenchymal hematoma volume on admission, were identified as significant determinants for chronic hydrocephalus. The nomogram demonstrated robust discriminative ability, with a C-index of 0.850 (95% confidence interval [CI] 0.791-0.909) in the training cohort and 0.785 (95% CI 0.649-0.922) in the validation cohort, surpassing the threshold of 0.70 for clinical utility. The area under the receiver operating characteristic curve was found to be 0.826 (95% CI 0.756-0.896) in the training set and 0.785 (95% CI 0.661-0.910) in the validation set. Furthermore, calibration curves and the Hosmer-Lemeshow test revealed favorable agreement between the nomogram model and actual observations. Decision curve analysis indicated that the nomogram provided clinical net benefit across threshold probabilities ranging from 8 to 80% in the training set and from 18 to 95% in the validation set.

CONCLUSIONS: This study developed and validated the first nomogram for assessing the risk of posthemorrhagic chronic hydrocephalus in patients with IVH, providing a valuable tool for individualized risk stratification and clinical decision-making. The study was registered on medicalresearch.org.cn (MR-50-23-048489).

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Du S, Zhang C, Mou L, et al. Development and Validation of a Novel Nomogram for Risk Stratification of Posthemorrhagic Chronic Hydrocephalus Following Intraventricular Hemorrhage: A Multicenter Retrospective Cohort Study. Neurocrit Care. 2026. PMID: 41507669. doi:10.1007/s12028-025-02421-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。